ArticleFrontiers in microbiology2025
Detection of viral contamination in cell lines using ViralCellDetector.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Background and aims: Cell lines are widely used in biomedical research to investigate various biological processes, including gene expression, cancer progression, and drug responses. However, cross-contamination with bacteria, mycoplasma, and viruses remains a persistent challenge. While the detection of bacterial and mycoplasma contamination is relatively straightforward, identifying viral contamination is more difficult. To address this issue, we developed ViralCellDetector, a tool designed to detect viral contamination by mapping RNA-seq data to a comprehensive viral genome library. Methods: ViralCellDetector processes RNA-seq data from any host species by first aligning reads to the host reference genome, followed by mapping the unmapped reads to the NCBI viral genome database. Viral presence is determined using stringent criteria based on the number of mapped reads and viral genome coverage. To further enable the detection of viral contamination from unknown sources, we identified host genes that are differentially expressed during viral infection and used these markers to train a machine learning model for classification. Results: Using ViralCellDetector, we found that approximately 10% (110 samples) of RNA-seq datasets involving MCF7 cells were likely contaminated with viruses. The tool demonstrated high sensitivity in detecting viral sequences. Furthermore, the machine learning model effectively distinguished infected from non-infected samples based on human gene expression profiles, achieving an AUC of 0.91 and an accuracy of 0.93. Conclusion: Our mapping-based approach enables robust detection of viral contamination in RNA-seq data from any host organism, while the marker-based approach accurately identifies viral infections specifically in human cell lines. This capability can help researchers detect and avoid the use of contaminated cell lines, thereby improving the reliability of experimental outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.